1. UPDATED RESULTS OF THE FIL "MIRO" STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA. (17th June 2021) Authors: Pulsoni, A.; Tosti, M. E.; Ferrero, S.; Luminari, S.; Dondi, A.; Liberati, A. M.; Cenfra, N.; Renzi, D.; Zanni, M.; Boccomini, C.; Ferreri, A. J.; Rattotti, S.; Zilioli, V. R.; Bernuzzi, P.; Bolis, S.; Musuraca, G.; Nassi, L.; Perrone, T.; Stelitano, C.; Anastasia, A. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. UPDATED RESULTS OF THE FIL "MIRO" STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA. (17th June 2021) Authors: Pulsoni, A.; Tosti, M. E.; Ferrero, S.; Luminari, S.; Dondi, A.; Liberati, A. M.; Cenfra, N.; Renzi, D.; Zanni, M.; Boccomini, C.; Ferreri, A. J.; Rattotti, S.; Zilioli, V. R.; Bernuzzi, P.; Bolis, S.; Musuraca, G.; Nassi, L.; Perrone, T.; Stelitano, C.; Anastasia, A. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗